GB9718986D0 - Controlled release microsphere delivery system - Google Patents
Controlled release microsphere delivery systemInfo
- Publication number
- GB9718986D0 GB9718986D0 GBGB9718986.4A GB9718986A GB9718986D0 GB 9718986 D0 GB9718986 D0 GB 9718986D0 GB 9718986 A GB9718986 A GB 9718986A GB 9718986 D0 GB9718986 D0 GB 9718986D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- delivery system
- controlled release
- release microsphere
- microsphere delivery
- controlled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9718986.4A GB9718986D0 (en) | 1997-09-09 | 1997-09-09 | Controlled release microsphere delivery system |
ZA9807762A ZA987762B (en) | 1997-09-09 | 1998-08-26 | Controlled release microsphere delivery system. |
EP98941610A EP1011680A2 (en) | 1997-09-09 | 1998-09-07 | Controlled release microsphere delivery system |
CA002302762A CA2302762A1 (en) | 1997-09-09 | 1998-09-07 | Controlled release microsphere delivery system |
PCT/GB1998/002692 WO1999012549A2 (en) | 1997-09-09 | 1998-09-07 | Controlled release microsphere delivery system |
NZ502710A NZ502710A (en) | 1997-09-09 | 1998-09-07 | Controlled release microsphere delivery system comprising a drug and a fatty acid |
AU89925/98A AU745511B2 (en) | 1997-09-09 | 1998-09-07 | Controlled release microsphere delivery system |
JP2000510446A JP2001515862A (en) | 1997-09-09 | 1998-09-07 | Controlled release microsphere delivery system |
ARP980104487A AR017079A1 (en) | 1997-09-09 | 1998-09-09 | A PHARMACEUTICAL COMPOSITION, A PROCEDURE FOR THE PREPARATION OF THE SAME, A TREATMENT METHOD AND ITS USE. |
NO20001219A NO20001219L (en) | 1997-09-09 | 2000-03-09 | Mixture for drug administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9718986.4A GB9718986D0 (en) | 1997-09-09 | 1997-09-09 | Controlled release microsphere delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9718986D0 true GB9718986D0 (en) | 1997-11-12 |
Family
ID=10818687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9718986.4A Ceased GB9718986D0 (en) | 1997-09-09 | 1997-09-09 | Controlled release microsphere delivery system |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1011680A2 (en) |
JP (1) | JP2001515862A (en) |
AR (1) | AR017079A1 (en) |
AU (1) | AU745511B2 (en) |
CA (1) | CA2302762A1 (en) |
GB (1) | GB9718986D0 (en) |
NO (1) | NO20001219L (en) |
NZ (1) | NZ502710A (en) |
WO (1) | WO1999012549A2 (en) |
ZA (1) | ZA987762B (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194006B1 (en) | 1998-12-30 | 2001-02-27 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of microparticles having a selected release profile |
US6705757B2 (en) | 1999-11-12 | 2004-03-16 | Alkermes Controlled Therapeutics, Inc. Ii | Method and apparatus for preparing microparticles using in-line solvent extraction |
US6331317B1 (en) | 1999-11-12 | 2001-12-18 | Alkermes Controlled Therapeutics Ii Inc. | Apparatus and method for preparing microparticles |
US6495166B1 (en) | 1999-11-12 | 2002-12-17 | Alkermes Controlled Therapeutics Inc. | Apparatus and method for preparing microparticles using in-line solvent extraction |
ES2169980B1 (en) * | 1999-12-17 | 2003-11-01 | Lipotec Sa | MICROCAPSULES FOR THE PROLONGED RELEASE OF PHARMACOS. |
US6264987B1 (en) | 2000-05-19 | 2001-07-24 | Alkermes Controlled Therapeutics Inc. Ii | Method for preparing microparticles having a selected polymer molecular weight |
US6495164B1 (en) | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
US6824822B2 (en) | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
US6471995B1 (en) | 2000-09-27 | 2002-10-29 | Alkermes Controlled Therapeutics, Inc. Ii | Apparatus and method for preparing microparticles using liquid-liquid extraction |
US20020114843A1 (en) | 2000-12-27 | 2002-08-22 | Ramstack J. Michael | Preparation of microparticles having improved flowability |
CA2490351C (en) | 2002-06-25 | 2011-11-01 | Takeda Pharmaceutical Company Limited | Process for producing sustained-release composition |
MXPA05004721A (en) * | 2002-10-31 | 2005-08-03 | Pfizer Prod Inc | Solid and semi-solid polymeric ionic conjugates. |
DK1675573T4 (en) | 2003-10-23 | 2012-08-06 | Otsuka Pharma Co Ltd | Controlled release sterile injectable aripiprazole formulation and method |
WO2005110425A1 (en) | 2004-04-15 | 2005-11-24 | Alkermes, Inc. | Polymer-based sustained release device |
CA2577852A1 (en) | 2004-08-31 | 2006-03-09 | Pfizer Products Inc. | Pharmaceutical dosage forms comprising a low-solubility drug and a polymer |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
EP3421031A1 (en) | 2006-08-09 | 2019-01-02 | Intarcia Therapeutics, Inc | Osmotic delivery systems and piston assemblies |
EP2089000A2 (en) * | 2006-10-05 | 2009-08-19 | Panacea Biotec Ltd. | Injectable depot composition and its process of preparation |
EP2094246B1 (en) | 2006-12-18 | 2020-04-01 | Takeda Pharmaceutical Company Limited | Sustained-release composition and method for producing the same |
CN101715340A (en) | 2007-04-23 | 2010-05-26 | 精达制药公司 | The mixed suspension preparation of insulinotropic peptide and application thereof |
CA2695178C (en) | 2007-07-31 | 2015-06-23 | Otsuka Pharmaceutical Co., Ltd. | Methods for producing aripiprazole suspension and freeze-dried formulation |
EP2240155B1 (en) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
SI2462246T1 (en) | 2009-09-28 | 2018-01-31 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
CN103458895B (en) * | 2010-11-25 | 2014-07-09 | 山东绿叶制药有限公司 | Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
JO3410B1 (en) | 2011-06-07 | 2019-10-20 | Otsuka Pharma Co Ltd | Freeze-dried aripiprazole formulation |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
KR102650751B1 (en) | 2015-06-03 | 2024-03-22 | 인타르시아 세라퓨틱스 인코포레이티드 | Implant placement and removal systems |
SG10201913699QA (en) | 2016-05-16 | 2020-03-30 | Intarcia Therapeutics Inc | Glucagon-receptor selective polypeptides and methods of use thereof |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
AU2018206539A1 (en) | 2017-01-03 | 2019-07-18 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
AU2018238136A1 (en) | 2017-03-20 | 2019-11-07 | Teva Pharmaceuticals International Gmbh | Sustained release olanzapine formulations |
KR102045721B1 (en) * | 2019-03-27 | 2019-11-18 | 주식회사 씨트리 | Compositions of dispersion phase for preparation of apixaban loaded microsphere and biocompatible polymer based apixaban loaded microsphere prepared therefrom |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4384975A (en) * | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres |
US4389330A (en) * | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
DK0669128T3 (en) * | 1992-11-17 | 2000-06-19 | Yoshitomi Pharmaceutical | Sustained-release microsphere containing antipsychotics and method of producing same |
EP0733368A1 (en) * | 1995-03-24 | 1996-09-25 | Eli Lilly And Company | Granule fomulation for olanzapine |
-
1997
- 1997-09-09 GB GBGB9718986.4A patent/GB9718986D0/en not_active Ceased
-
1998
- 1998-08-26 ZA ZA9807762A patent/ZA987762B/en unknown
- 1998-09-07 AU AU89925/98A patent/AU745511B2/en not_active Ceased
- 1998-09-07 WO PCT/GB1998/002692 patent/WO1999012549A2/en not_active Application Discontinuation
- 1998-09-07 CA CA002302762A patent/CA2302762A1/en not_active Abandoned
- 1998-09-07 NZ NZ502710A patent/NZ502710A/en unknown
- 1998-09-07 EP EP98941610A patent/EP1011680A2/en not_active Withdrawn
- 1998-09-07 JP JP2000510446A patent/JP2001515862A/en active Pending
- 1998-09-09 AR ARP980104487A patent/AR017079A1/en unknown
-
2000
- 2000-03-09 NO NO20001219A patent/NO20001219L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20001219D0 (en) | 2000-03-09 |
AR017079A1 (en) | 2001-08-22 |
AU745511B2 (en) | 2002-03-21 |
WO1999012549A2 (en) | 1999-03-18 |
NZ502710A (en) | 2001-09-28 |
NO20001219L (en) | 2000-03-09 |
JP2001515862A (en) | 2001-09-25 |
WO1999012549A3 (en) | 1999-05-06 |
CA2302762A1 (en) | 1999-03-18 |
AU8992598A (en) | 1999-03-29 |
ZA987762B (en) | 2000-02-28 |
EP1011680A2 (en) | 2000-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9718986D0 (en) | Controlled release microsphere delivery system | |
GB9710699D0 (en) | Gastro-retentive controlled release system | |
SG80049A1 (en) | Delivery system | |
HUP0004945A3 (en) | Delayed total release gastrointestinal drug delivery system | |
EP1015971A4 (en) | Reliable event delivery system | |
GB2324395B (en) | Entertainment system | |
IL120943A0 (en) | Transdermal delivery system | |
HK1035135A1 (en) | Sustained release drug delivery devices | |
ZA972288B (en) | Vitamin c delivery system | |
PL336122A1 (en) | Braking system | |
ZA971943B (en) | Vitamin C delivery system | |
AU8374498A (en) | Combination counter-ejector shingle-output delivery system | |
EP0989878A4 (en) | Drug delivery system | |
AU1709197A (en) | Time release delivery system | |
GB9721367D0 (en) | Delivery system | |
EP1021137A4 (en) | Drug delivery system | |
EP0913159A4 (en) | Drug delivery system using galactoxyloglucan | |
GB2365338B (en) | Therapeutic systems | |
GB9706236D0 (en) | Cement delivery system | |
AU5128498A (en) | Microsphere reservoirs for controlled release application | |
GB9717643D0 (en) | Braking system | |
GB9600471D0 (en) | Drug delivery system | |
GB9919664D0 (en) | Slow release delivery system | |
GB9700355D0 (en) | Drug delivery system | |
IL121701A0 (en) | Controlled parachute system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |